Ander Estella‐Hermoso de Mendoza
Publications by Year
Research Areas
Lipid Membrane Structure and Behavior, Histone Deacetylase Inhibitors Research, Toxin Mechanisms and Immunotoxins, Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery
Most-Cited Works
- → Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies(2017)166 cited
- → Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease(2019)156 cited
- → Nanomedicine and drug delivery systems in cancer and regenerative medicine(2020)126 cited
- → Lipid raft-targeted therapy in multiple myeloma(2010)122 cited
- → In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma(2011)110 cited
- → GPR55: A therapeutic target for Parkinson's disease?(2017)104 cited
- → In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts(2010)90 cited
- → Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease(2016)85 cited
- → Lipid Nanomedicines for Anticancer Drug Therapy(2009)79 cited
- → Lipid nanoparticles for cancer therapy: state of the art and future prospects(2012)79 cited